Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
- Author
- CAVO, Michele1 ; PANTANI, Lucia1 ; NOZZOLI, Chiara8 ; ZAMBELLO, Renato9 ; MASINI, Luciano10 ; FURLAN, Anna11 ; BRIOLI, Annamaria1 ; DERUDAS, Daniele12 ; BALLANTI, Stelvio13 ; LAURA DESSANTI, Maria14 ; DE STEFANO, Valerio15 ; CARELLA, Angelo Michele16 ; TERESA PETRUCCI, Maria2 ; MARCATTI, Magda17 ; NOZZA, Andrea18 ; FERRARA, Felicetto19 ; CALLEA, Vincenzo20 ; CALIFANO, Catello21 ; PEZZI, Annalisa1 ; BARALDI, Anna22 ; GRASSO, Mariella23 ; MUSTO, Pellegrino24 ; PALUMBO, Antonio6 ; PATRIARCA, Francesca3 ; ZAMAGNI, Elena1 ; DONNARUMMA, Daniela4 ; CRIPPA, Claudia5 ; BOCCADORO, Mario6 ; PERRONE, Giulia1 ; FALCONE, Antonietta7
[1] Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
[2] Cattedra di Ematologia, Università La Sapienza, Roma, Italy
[3] C]inica Ematologica, Policlinico Universitario, Udine, Italy
[4] Cattedra di Ematologia, Ospedale Ferrarotto, Catania, Italy
[5] Struttura Complessa di Ematologia e Dipartimento di Oncologia Medica, Spedali Civili, Brescia, Italy
[6] Unità Operativa di Ematologia, AOU S. Giovanni Battista, Ospedale Molinette, Torino, Italy
[7] Divisione di Ematologia, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
[8] Cattedra di Ematologia, Policlinico Careggi, Firenze, Italy
[9] Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Padova, Padova, Italy
[10] Unità di Ematologia, Dipartimento di Oncologia, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy
[11] Struttura Complessa di Ematologia, Ospedale Ca' Foncello, Treviso, Italy
[12] Unità Operativa di Ematologia, Ospedale Oncologico Businco, Cagliari, Italy
[13] Sezione di Ematologia ed Immunologia Clinica, Ospedale Silvestrini S. Maria della Misericordia, Perugia, Italy
[14] Struttura Complessa di Ematologia, Istituto Regina Elena-IFO, Roma, Italy
[15] Istituto di Ematologia, Università Cattolica, Roma, Italy
[16] Dipartimento di Ematologia e Oncologia, Azienda Ospedaliera Universitaria San Martino, Genova, Italy
[17] Unità Operativa di Ematologia e Trapianto di Midollo, Istituto Scientifico San Raffaele, Milano, Italy
[18] Dipartimento di Oncologia e Ematologia, Istituto Clinico Humanitas, Milano, Italy
[19] Unità di Ematologia, Ospedale Cardarelli, Napoli, Italy
[20] Unità di Ematologia, Ospedale Bianchi-Melacrinò-Morelli, Reggio Calabria, Italy
[21] Unità di Ematologia, Nocera Inferiore, Italy
[22] Struttura Operativa Complessa di Ematologia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
[23] Dipartimento di Ematologia e Trapianto di Midollo, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy
[24] Oncoematologia, Istituto di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (PZ), Italy
GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network, Italy - Source
Blood. 2012, Vol 120, Num 1, pp 9-19, 11 p ; ref : 35 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Anticancéreux Bortézomib Cellule hématopoïétique Cellule souche Dexaméthasone Homme Hématologie Myélome Stade précoce Thalidomide Traitement consolidation Acide boronique Autogreffe de cellules souches hématopoïétiques Analogue Anti-TNF-alpha Cancer Corticostéroïde Dipeptide Hormone stéroïde Hémopathie maligne Immunoglobulinopathie Immunopathologie Inhibiteur du protéasome Syndrome lymphoprolifératif
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Bortezomib Hematopoietic cell Stem cell Dexamethasone Human Hematology Myeloma Early stage Thalidomide Consolidation treatment Autologous hematopoietic stem cell transplantation Analog Anti-Tumor Necrosis Factor-alpha Cancer Corticosteroid Dipeptides Steroid hormone Malignant hemopathy Immunoglobulinopathy Immunopathology Proteasome inhibitor Lymphoproliferative syndrome
- Keyword (es)
- Antiangiogenico Anticanceroso Bortezomib Célula hematopoyética Célula primitiva Dexametasona Hombre Hematología Mieloma Estadio precoz Talidomida Tratamiento de consolidación Autoinjerto de células precursoras hematopoyéticas Análogo Anti-TNF alfa Cáncer Corticoesteroide Dipéptido Hormona esteroide Hemopatía maligna Inmunoglobulinopatía Inmunopatología Inhibidor proteasome Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Immunopathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26132895
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood-2012-02-408898 
https://dx.doi.org/10.1182/blood-2012-02-408898
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"120\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"9\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAVO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:29:{i:0;s:14:\"PANTANI, Lucia\";i:1;s:15:\"NOZZOLI, Chiara\";i:2;s:16:\"ZAMBELLO, Renato\";i:3;s:15:\"MASINI, Luciano\";i:4;s:12:\"FURLAN, Anna\";i:5;s:17:\"BRIOLI, Annamaria\";i:6;s:16:\"DERUDAS, Daniele\";i:7;s:17:\"BALLANTI, Stelvio\";i:8;s:21:\"LAURA DESSANTI, Maria\";i:9;s:19:\"DE STEFANO, Valerio\";i:10;s:23:\"CARELLA, Angelo Michele\";i:11;s:22:\"TERESA PETRUCCI, Maria\";i:12;s:15:\"MARCATTI, Magda\";i:13;s:13:\"NOZZA, Andrea\";i:14;s:18:\"FERRARA, Felicetto\";i:15;s:16:\"CALLEA, Vincenzo\";i:16;s:17:\"CALIFANO, Catello\";i:17;s:15:\"PEZZI, Annalisa\";i:18;s:13:\"BARALDI, Anna\";i:19;s:16:\"GRASSO, Mariella\";i:20;s:17:\"MUSTO, Pellegrino\";i:21;s:16:\"PALUMBO, Antonio\";i:22;s:20:\"PATRIARCA, Francesca\";i:23;s:14:\"ZAMAGNI, Elena\";i:24;s:19:\"DONNARUMMA, Daniela\";i:25;s:15:\"CRIPPA, Claudia\";i:26;s:16:\"BOCCADORO, Mario\";i:27;s:15:\"PERRONE, Giulia\";i:28;s:19:\"FALCONE, Antonietta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"120\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"9\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAVO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:29:{i:0;s:14:\"PANTANI, Lucia\";i:1;s:15:\"NOZZOLI, Chiara\";i:2;s:16:\"ZAMBELLO, Renato\";i:3;s:15:\"MASINI, Luciano\";i:4;s:12:\"FURLAN, Anna\";i:5;s:17:\"BRIOLI, Annamaria\";i:6;s:16:\"DERUDAS, Daniele\";i:7;s:17:\"BALLANTI, Stelvio\";i:8;s:21:\"LAURA DESSANTI, Maria\";i:9;s:19:\"DE STEFANO, Valerio\";i:10;s:23:\"CARELLA, Angelo Michele\";i:11;s:22:\"TERESA PETRUCCI, Maria\";i:12;s:15:\"MARCATTI, Magda\";i:13;s:13:\"NOZZA, Andrea\";i:14;s:18:\"FERRARA, Felicetto\";i:15;s:16:\"CALLEA, Vincenzo\";i:16;s:17:\"CALIFANO, Catello\";i:17;s:15:\"PEZZI, Annalisa\";i:18;s:13:\"BARALDI, Anna\";i:19;s:16:\"GRASSO, Mariella\";i:20;s:17:\"MUSTO, Pellegrino\";i:21;s:16:\"PALUMBO, Antonio\";i:22;s:20:\"PATRIARCA, Francesca\";i:23;s:14:\"ZAMAGNI, Elena\";i:24;s:19:\"DONNARUMMA, Daniela\";i:25;s:15:\"CRIPPA, Claudia\";i:26;s:16:\"BOCCADORO, Mario\";i:27;s:15:\"PERRONE, Giulia\";i:28;s:19:\"FALCONE, Antonietta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"120\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"9\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAVO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:29:{i:0;s:14:\"PANTANI, Lucia\";i:1;s:15:\"NOZZOLI, Chiara\";i:2;s:16:\"ZAMBELLO, Renato\";i:3;s:15:\"MASINI, Luciano\";i:4;s:12:\"FURLAN, Anna\";i:5;s:17:\"BRIOLI, Annamaria\";i:6;s:16:\"DERUDAS, Daniele\";i:7;s:17:\"BALLANTI, Stelvio\";i:8;s:21:\"LAURA DESSANTI, Maria\";i:9;s:19:\"DE STEFANO, Valerio\";i:10;s:23:\"CARELLA, Angelo Michele\";i:11;s:22:\"TERESA PETRUCCI, Maria\";i:12;s:15:\"MARCATTI, Magda\";i:13;s:13:\"NOZZA, Andrea\";i:14;s:18:\"FERRARA, Felicetto\";i:15;s:16:\"CALLEA, Vincenzo\";i:16;s:17:\"CALIFANO, Catello\";i:17;s:15:\"PEZZI, Annalisa\";i:18;s:13:\"BARALDI, Anna\";i:19;s:16:\"GRASSO, Mariella\";i:20;s:17:\"MUSTO, Pellegrino\";i:21;s:16:\"PALUMBO, Antonio\";i:22;s:20:\"PATRIARCA, Francesca\";i:23;s:14:\"ZAMAGNI, Elena\";i:24;s:19:\"DONNARUMMA, Daniela\";i:25;s:15:\"CRIPPA, Claudia\";i:26;s:16:\"BOCCADORO, Mario\";i:27;s:15:\"PERRONE, Giulia\";i:28;s:19:\"FALCONE, Antonietta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"120\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"9\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAVO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:29:{i:0;s:14:\"PANTANI, Lucia\";i:1;s:15:\"NOZZOLI, Chiara\";i:2;s:16:\"ZAMBELLO, Renato\";i:3;s:15:\"MASINI, Luciano\";i:4;s:12:\"FURLAN, Anna\";i:5;s:17:\"BRIOLI, Annamaria\";i:6;s:16:\"DERUDAS, Daniele\";i:7;s:17:\"BALLANTI, Stelvio\";i:8;s:21:\"LAURA DESSANTI, Maria\";i:9;s:19:\"DE STEFANO, Valerio\";i:10;s:23:\"CARELLA, Angelo Michele\";i:11;s:22:\"TERESA PETRUCCI, Maria\";i:12;s:15:\"MARCATTI, Magda\";i:13;s:13:\"NOZZA, Andrea\";i:14;s:18:\"FERRARA, Felicetto\";i:15;s:16:\"CALLEA, Vincenzo\";i:16;s:17:\"CALIFANO, Catello\";i:17;s:15:\"PEZZI, Annalisa\";i:18;s:13:\"BARALDI, Anna\";i:19;s:16:\"GRASSO, Mariella\";i:20;s:17:\"MUSTO, Pellegrino\";i:21;s:16:\"PALUMBO, Antonio\";i:22;s:20:\"PATRIARCA, Francesca\";i:23;s:14:\"ZAMAGNI, Elena\";i:24;s:19:\"DONNARUMMA, Daniela\";i:25;s:15:\"CRIPPA, Claudia\";i:26;s:16:\"BOCCADORO, Mario\";i:27;s:15:\"PERRONE, Giulia\";i:28;s:19:\"FALCONE, Antonietta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1182\/blood-2012-02-408898\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"120\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"9\";s:8:\"\u0000*\u0000epage\";s:2:\"19\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"CAVO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Michele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:29:{i:0;s:14:\"PANTANI, Lucia\";i:1;s:15:\"NOZZOLI, Chiara\";i:2;s:16:\"ZAMBELLO, Renato\";i:3;s:15:\"MASINI, Luciano\";i:4;s:12:\"FURLAN, Anna\";i:5;s:17:\"BRIOLI, Annamaria\";i:6;s:16:\"DERUDAS, Daniele\";i:7;s:17:\"BALLANTI, Stelvio\";i:8;s:21:\"LAURA DESSANTI, Maria\";i:9;s:19:\"DE STEFANO, Valerio\";i:10;s:23:\"CARELLA, Angelo Michele\";i:11;s:22:\"TERESA PETRUCCI, Maria\";i:12;s:15:\"MARCATTI, Magda\";i:13;s:13:\"NOZZA, Andrea\";i:14;s:18:\"FERRARA, Felicetto\";i:15;s:16:\"CALLEA, Vincenzo\";i:16;s:17:\"CALIFANO, Catello\";i:17;s:15:\"PEZZI, Annalisa\";i:18;s:13:\"BARALDI, Anna\";i:19;s:16:\"GRASSO, Mariella\";i:20;s:17:\"MUSTO, Pellegrino\";i:21;s:16:\"PALUMBO, Antonio\";i:22;s:20:\"PATRIARCA, Francesca\";i:23;s:14:\"ZAMAGNI, Elena\";i:24;s:19:\"DONNARUMMA, Daniela\";i:25;s:15:\"CRIPPA, Claudia\";i:26;s:16:\"BOCCADORO, Mario\";i:27;s:15:\"PERRONE, Giulia\";i:28;s:19:\"FALCONE, Antonietta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:209:\"Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:31:\"Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
